drugset / Trial / NCT01346657
The Effect of LipoCol Forte® Capsules on the Pharmacokinetics of Nifedipine After Administering Single-dose Combination to Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of the study is to evaluate the effect of LipoCol Forte® Capsules on the pharmacokinetics of nifedipine after administering single-dose combination to healthy subjects using a 2x2 crossover design.
Timeline
- Start
- 2009-07
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LipoCol | Unknown | 600 mg | — |
| Subject | Nifedipine | Other / unclassified | 5 mg | — |
Indications
No indication recorded.